Abstract
Early stage cervical cancer is treated with radical surgery or definitive irradiation. There is no consensus as to the use of adjuvant pelvic irradiation for patients who have undergone radical hysterectomy. Several pathological indicators are predictors of local pelvic disease recurrence. Positive pelvic lymph nodes, large tumor size, stromal penetration, and vascular invasion are factors that have a negative impact on local control and 5-year survival rates. The presence of one or more of these findings may influence the decision to incorporate pelvic irradiation into the postoperative treatment plan of a women with cervical cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
